Draft points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials

On 25th March, EMA issued a draft guidance for consultation with deadline for comments on 25th April. https://www.ema.europa.eu/en/documents/scientific-guideline/points-consider-implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical_en.pdf

Read More "Draft points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials"

Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

On 20th of March, The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA) have published new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic. The impact of the pandemic on European health systems and more broadly […]

Read More "Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic"

Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019

Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019 Date & Time: 17 April 2019 from 3:30 PM to 5:00 PM (CET)    Attendance Fee: € 90,- for EUCROF non-members € 60,- for EUCROF members using the code DATA0417 Register here    

Read More "Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019"

Direct to Patient (D2P) shipment for Clinical Trials – Survey

Direct to Patient (D2P) shipment for Clinical Trials – Survey Dear Sponsor, CRO, Investigator or Patient, Within Europe and more specifically within Belgium, Direct To Patient (D2P) shipments have limitations within the current regulatory framework. Considering the growing enthusiasm of pharma companies, investigators and patients performing D2P shipments in the US, we need to investigate […]

Read More "Direct to Patient (D2P) shipment for Clinical Trials – Survey"

BeCRO invited in Tokyo to promote Belgium as a gateway to clinical research in Europe

BeCRO invited in Tokyo to promote Belgium as a gateway to clinical research in Europe Bruxelles Invest & Export invited BeCRo to present the attractivness of Brussels for clinical trials in the European Union, during the Brussels Days in Tokyo on May 18, 2016. This event was organized on the occasion of celebrating 150 years […]

Read More "BeCRO invited in Tokyo to promote Belgium as a gateway to clinical research in Europe"

BeCRO co-organizer of a luncheon event, at BIO 2016 in San Francisco

BeCRO co-organizer of a luncheon event, at BIO 2016 in San Francisco, introduced by Minister Maggie De Block   Bio San Francisco on June 7, 2016 : BeCRO co-organized with Bruxelles Invest & Export a luncheon event, introduced by Belgian Federal Minister of Public Health and Social Affairs, Maggie De Block, to reinforce Belgium’s commitment […]

Read More "BeCRO co-organizer of a luncheon event, at BIO 2016 in San Francisco"

Need more information ?

BECRO

PLACE MARCEL BROODTHAERS PLEIN, 8 BOX 5
B-1060 BRUSSELS / BELGIUM
PHONE: +32 (0)2 892 40 00
E-MAIL: INFO@BECRO.BE

© 2018 BECRO – ALL RIGHTS RESERVED

Octopix + WordPress = ♥ | Design by Simplexity